Replies to post #26385 on Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

There's a reason institutional money is waiting to initiate and that reason is simple...for them IPCI is currently at a "show me" stage. But I would certainly laugh my ass off if the SEC would step in and pull the blue sheets over the past 3 years...as I have no doubt whatsoever that the same group wash trading/manipulating the action here over the past 3 years would clearly be exposed by a forensic audit of the action...and everyone familiar with this stock already knows they're the same group that was responsible for last years halt and subsequent TSX investigation over the fake rumor mill hogwash they put out.

No bigger turn off for institutional money and joe retail than a bunch of rich schmucks purposely screwing with a company's market thinking they're untouchable.

I know for a fact that many joe retail players have sold IPCI until such time its market starts behaving normally...all anyone has to do is buy this stock and hold it for a few weeks and/or months to see it's under constant manipulation.

[Tekterra]

It's double edged sward Sam, the keyword here is premature like you said. One can argue in both directions as much as they want.

You say the company will be cash flow positive, wouldn't that statement be a bit premature as well? Right?

The stock reflects what the general public feels about IPCI right now.
Can IPCI secure a Rexista deal to pave the way for advancing the pipeline? That may also generate enough funding to go into the next year or two at the very least.

I kept myself from buying a lot more shares just yet because I too felt the same way. Management can say what they want, whether or not they deliver is what really matters.

I am not looking just for break even. As I said, biotech needs to be constantly advancing their pipeline. They might be break even now, but we know competition will eventually drive profit lower as seen with Facolin. You see why people aren't willing to hold just yet? Simply because there is nothing that secures a big upside for the future.

As IPCI gets more approval, and increase revenue, it will make a lot more investors feel at ease buying and holding. A Rexista and PODRAS deal would really be the key to the future. But again, using your word, it's a bit premature wouldn't you say?

I am not saying IPCI will fail or anything, I'm just pointing out what general public feels about IPCI right now. On watch but won't commit just yet.